Louise-Marie Dembry, MD, FACP, MS, MBA, FIDSA, BS
DownloadHi-Res Photo
Cards
Appointments
Infectious Diseases
Primary
Contact Info
About
Titles
Professor Emeritus of Medicine
Biography
Dr. Dembry is Professor of Medicine, Infectious Diseases and Epidemiology at Yale University. She was the Yale-New Haven Hospital (YNHH) Associate Director and Director of Hospital Epidemiology from 1993-2015. She is currently Director of Hospital Epidemiology for the VA CT Healthcare System. She has held multiple hospital leadership positions at both YNHH and the VA CT Healthcare System. She was President of the Society for Healthcare Epidemiology of America (SHEA) and Board Chairperson in 2016 and served as the SHEA liaison to CDC's Healthcare Infection Control Practices Advisory Committee (HICPAC) 2017-2021. She is a member of the Connecticut Healthcare Associated Infection Advisory Committee appointed by the Commissioner of Public Health and is a member of the CT DPH HAI Multidisciplinary Antimicrobial Resistance Advisory Group. Her main interests include 1) the prevention and control of transmission of antibiotic resistant organisms in healthcare settings, 2) patient safety, 3) healthcare facility preparedness for high consequence infections and 4) training and education for hospital epidemiology and public health emergencies.
Appointments
Infectious Diseases
EmeritusPrimary
Other Departments & Organizations
Education & Training
- MBA
- University of New Haven (2008)
- Fellow
- Wayne State University Hospitals (1993)
- Chief Resident
- Wayne State University (1990)
- Resident
- Wayne State University (1989)
- MD
- Wayne State University (1986)
- MS
- Wayne State University, Biology (1981)
- BS
- University of Michigan, Zoology (1980)
Board Certifications
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 1989
Research
Overview
Medical Subject Headings (MeSH)
Enterococcus; Epidemiology; Infectious Disease Medicine; Public Health; Public Health Surveillance; Vancomycin-Resistant Enterococci
ORCID
0000-0003-4366-5283
Research at a Glance
Yale Co-Authors
Frequent collaborators of Louise-Marie Dembry's published research.
Publications Timeline
A big-picture view of Louise-Marie Dembry's research output by year.
Research Interests
Research topics Louise-Marie Dembry is interested in exploring.
Patrick Gallagher, MD, BS
Rupak Datta, MD/PhD, MPH
David Banach, MD, MPH, MS
Manisha Juthani, MD
Richard A Martinello, MD
Vincent Quagliarello, MD
95Publications
2,545Citations
Enterococcus
Epidemiology
Infectious Disease Medicine
Publications
2022
Epidemiology and outcomes of surgical site infections among pediatric liver transplant recipients
Banach DB, Lopez‐Verdugo F, Sanchez‐Garcia J, Tran A, Gomez‐Llerena A, Munoz‐Abraham A, Bertacco A, Valentino PL, Yoo P, Dembry L, Mulligan DC, Ekong UD, Emre SH, Rodriguez‐Davalos M. Epidemiology and outcomes of surgical site infections among pediatric liver transplant recipients. Transplant Infectious Disease 2022, 24: e13941. PMID: 35989545, DOI: 10.1111/tid.13941.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsSurgical site infectionLiver transplant recipientsLiver transplantationBiliary complicationsGraft recipientsTransplant recipientsSite infectionRisk factorsOutcomes of SSIPediatric liver transplant recipientsLong-term graftPediatric liver transplantationRetrospective descriptive analysisPrimary endpointHospital daysPatient agePediatric populationPatient survivalSignificant causeComplicationsPatientsRecipientsOutcomesInfectionIncidenceClinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy
Tuan J, Kayani J, Fisher A, Kotansky B, Dembry L, Datta R. Clinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy. Antimicrobial Stewardship & Healthcare Epidemiology 2022, 2: e83. PMID: 36483361, PMCID: PMC9726471, DOI: 10.1017/ash.2022.229.Peer-Reviewed Original ResearchCitationsAltmetricConceptsDalbavancin administrationOutpatient parenteral antimicrobial therapyDose of dalbavancinMedian antibiotic durationSoft tissue infectionsParenteral antimicrobial therapyAntibiotic durationDeveloped hepatotoxicityClinical cureSeptic arthritisClinical outcomesAntimicrobial therapyPatientsAdministrationDaysEndocarditisArthritisBacteremiaOsteomyelitisHepatotoxicityTherapyDalbavancinInfectionDoseComparison of traditional instruction versus nontraditional learning to improve trainee knowledge of urine culture practices in catheterized patients
Gao CA, Datta R, Dunne D, Dembry LM, Martinello RA, Juthani-Mehta M, Advani SD. Comparison of traditional instruction versus nontraditional learning to improve trainee knowledge of urine culture practices in catheterized patients. Antimicrobial Stewardship & Healthcare Epidemiology 2022, 2: e81. PMID: 35647610, PMCID: PMC9139028, DOI: 10.1017/ash.2022.225.Peer-Reviewed Original ResearchCitationsAltmetric
2021
Focal renal infections and papillary necrosis
Fisher A, Dembry L. Focal renal infections and papillary necrosis. 2021, 433-438. DOI: 10.1093/med/9780190888367.003.0067.Peer-Reviewed Original ResearchConceptsAcute focal bacterial nephritisPapillary necrosisIntrarenal abscessXanthogranulomatous pyelonephritisRenal infectionAcute multifocal bacterial nephritisRenal cortical abscessRenal medullary vasculatureUrinary tract obstructionFocal bacterial nephritisVariety of syndromesCortical abscessesRenal corticomedullaryPerirenal abscessRenal impairmentTract obstructionClinicopathologic syndromeIschemic necrosisFocal infectionMedullary vasculatureAbscessRenal medullaNecrosisInfectionPerinephric fasciaEvidence-Based Interventions for Antimicrobial Resistance in Conflict-Afflicted Arab Countries
Reffat N, Khoshnood K, Dembry L. Evidence-Based Interventions for Antimicrobial Resistance in Conflict-Afflicted Arab Countries. 2021, 3177-3201. DOI: 10.1007/978-3-030-36811-1_213.Peer-Reviewed Original ResearchSurveillance of adverse drug events associated with tocilizumab in hospitalized veterans with coronavirus disease 2019 (COVID-19) to inform patient safety and pandemic preparedness
Datta R, Barrett A, Burk M, Salone C, Au A, Cunningham F, Fisher A, Dembry LM, Akgün KM. Surveillance of adverse drug events associated with tocilizumab in hospitalized veterans with coronavirus disease 2019 (COVID-19) to inform patient safety and pandemic preparedness. Infection Control And Hospital Epidemiology 2021, 43: 1488-1491. PMID: 33985598, PMCID: PMC8160489, DOI: 10.1017/ice.2021.227.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsEvidence-Based Interventions for Antimicrobial Resistance in Conflict-Afflicted Arab Countries
Reffat N, Khoshnood K, Dembry L. Evidence-Based Interventions for Antimicrobial Resistance in Conflict-Afflicted Arab Countries. 2021, 1-25. DOI: 10.1007/978-3-319-74365-3_213-2.Peer-Reviewed Original ResearchIncreasing face-mask compliance among healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic
Datta R, Glenn K, Pellegrino A, Tuan J, Linde B, Kayani J, Patel K, Calo L, Dembry LM, Fisher A. Increasing face-mask compliance among healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic. Infection Control And Hospital Epidemiology 2021, 43: 616-622. PMID: 33938417, PMCID: PMC8144836, DOI: 10.1017/ice.2021.205.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsEvidence-Based Interventions for Antimicrobial Resistance in Conflict-Afflicted Arab Countries
Reffat N, Khoshnood K, Dembry L. Evidence-Based Interventions for Antimicrobial Resistance in Conflict-Afflicted Arab Countries. 2021, 1-25. DOI: 10.1007/978-3-319-74365-3_213-1.Peer-Reviewed Original ResearchAltmetric
2020
Management of healthcare personnel living with hepatitis B, hepatitis C, or human immunodeficiency virus in US healthcare institutions
Henderson DK, Dembry LM, Sifri CD, Palmore TN, Dellinger EP, Yokoe DS, Grady C, Heller T, Weber D, del Rio C, Fishman NO, Deloney VM, Lundstrom T, Babcock HM. Management of healthcare personnel living with hepatitis B, hepatitis C, or human immunodeficiency virus in US healthcare institutions. Infection Control And Hospital Epidemiology 2020, 43: 147-155. PMID: 33050959, DOI: 10.1017/ice.2020.458.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and Concepts
Academic Achievements and Community Involvement
activity Member
CommitteesCT Department of Public HealthDetails11/01/2002 - PresentDescriptionReportable Diseases Advisory Committeeactivity Member
CommitteesCT Department of Public HealthDetails08/01/2006 - PresentDescriptionCommittee on Healthcare Acquired Infections (voting member)activity Board Member
Public ServiceHabitat for Humanity New HavenDetails2021 - Presentactivity Committee Member
Professional OrganizationsSociety for Healthcare Epidemiology of AmericaDetails09/01/2019 - Presentactivity Board of Directors
Public ServiceVNA Community Healthcare and HospiceDetails2017 - 2022DescriptionBoard Secretary
Links & Media
News
- December 06, 2022
Retiring Dr. Louise-Marie Dembry Looking to Reconnect
- February 15, 2018
PA Program Thesis Projects Advance Research While Building Student-Faculty Relationships
- February 25, 2015
Spotlight on meningitis: Q&A with Dr. Louise-Marie Dembry
- February 05, 2015
Doctors to patients: Get your measles vaccine
Related Links
Get In Touch
Contacts
Academic Office Number
Locations
Infectious Diseases
Academic Office
The Anlyan Center
300 Cedar Street, Ste TAC S169
New Haven, CT 06519
General Information
203.785.4140